3rd Annual Atlanta Precision Oncology Symposium

 

3rd Annual Atlanta Precision Oncology Symposium
N

Selecting Systemic First-Line Treatment in Stage IV NSCLC Without Driver Mutations: ASCO/CCO Updated Guidelines

By 3rd Annual Atlanta Precision Oncology Symposium FEATURING Nasser Hanna
By 3rd Annual Atlanta Precision Oncology Symposium FEATURING Nasser Hanna
324 views
February 14, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

05:15
Lilly Medical Affairs

Unmet Needs for Patients With HR+, HER2- Early Breast Cancer at a Hi…

Feat. H. Rugo
Videos
12:36

Genotype-Directed Therapy for Advanced NSCLC: Overview of Targeted T…

3rd Annual Atlanta Precision Oncology Symposium

H. Borghaei

539 views
26:48

Targeted Therapies for Advanced Urothelial Cancer: Erdafitinib for P…

3rd Annual Atlanta Precision Oncology Symposium

D. Petrylak

146 views
13:52

Targeted Therapy for Advanced NSCLC: Efficacy Analysis of RET, KRAS,…

3rd Annual Atlanta Precision Oncology Symposium

H. Borghaei

35 views
25:48

2021 Expert Discussion on GU Cancers: Should We Use Olaparib Before …

3rd Annual Atlanta Precision Oncology Symposium

E. Antonarakis, D. Petrylak, T. Zhang

233 views
26:48

Treatment of DNA Repair-Deficient Advanced Prostate Cancer

3rd Annual Atlanta Precision Oncology Symposium

E. Antonarakis

241 views
26:42

2021 Expert Discussion on Advanced NSCLC: Is Osimertinib a Good Sequ…

3rd Annual Atlanta Precision Oncology Symposium

E. Garon, N. Hanna, H. Borghaei, J. Kirkpatrick

390 views
23:13

Early Detection of Lung Cancer: Molecular Enrichment Strategy

3rd Annual Atlanta Precision Oncology Symposium

J. Kirkpatrick

95 views
18:36

Selecting Systemic First-Line Treatment in Stage IV NSCLC Without Dr…

3rd Annual Atlanta Precision Oncology Symposium

N. Hanna

324 views
20:20

2021 Expert Discussion on BC: How to Preoperatively Manage TNBC? How…

3rd Annual Atlanta Precision Oncology Symposium

I. Mayer, J. Litton, R. O’Regan

31 views
32:45

2021 Updates on Systemic Therapy for TNBC: Why Should We Choose Neoa…

3rd Annual Atlanta Precision Oncology Symposium

R. O’Regan

40 views
06:49

IO for mTNBC: Overview of the Efficacy Data

3rd Annual Atlanta Precision Oncology Symposium

J. Litton

345 views
13:30

ADCs & Targeted Therapies for Advanced TNBC: Can Sacituzumab Govitec…

3rd Annual Atlanta Precision Oncology Symposium

J. Litton

96 views
09:52

EGFR+ Advanced NSCLC: Should 1L Therapy Include an EGFR Inhibitor Re…

3rd Annual Atlanta Precision Oncology Symposium

E. Garon

98 views
15:01

EGFR+ Advanced NSCLC: Efficacy Data of TKIs in Combination vs. Alone…

3rd Annual Atlanta Precision Oncology Symposium

E. Garon

141 views
05:55

Sequence Algorithm for HER2+ Breast Cancer: Does Neratinib + Cape Ha…

3rd Annual Atlanta Precision Oncology Symposium

I. Mayer

28 views
05:03

CNS Metastases in HER2+ MBC: PFS Data on the Addition of Tucatinib t…

3rd Annual Atlanta Precision Oncology Symposium

I. Mayer

599 views
17:47

HER2+ MBC Sequencing Algorithm: Surveying the Data for Antibody-Drug…

3rd Annual Atlanta Precision Oncology Symposium

I. Mayer

33 views
14:04
3rd Annual Atlanta Precision Oncology Symposium

[PRIVATE] Targeted Therapies for mRCC: Surveying Efficacy Data for I…

Feat. T. Zhang
17:05
3rd Annual Atlanta Precision Oncology Symposium

[PRIVATE] Targeted Therapies for mRCC: Assessing IMDC Risk Criteria …

Feat. T. Zhang
08:45

Targeting Genetic Mutations in mNSCLC: Clinical Data Overview of RET…

3rd Annual Atlanta Precision Oncology Symposium

H. Dilks

282 views